glp 1 and gip dual agonist The Effects of GLP-1/GIP Receptor Agonism on Glucagon Secretion—A Review Dual GLP-1/GIP Agonist | Tirzepatide

The majority of available studies have focussed on cohorts of patients with new-onset diabetes following solid organ transplantation or on oncological patients

doi: 10.3389/fimmu.2019.01223

Patients only need to inject it once a week for the blood sugar control of adults with type II diabetes mellitus

The main difference is administration

Therefore, this review presents the triangle relationship of obesity, DM as well as cancer development and elucidates the treatment of overweight-associated T2DM with semaglutide, focusing on the question of whether the development of these conditions can be combated or if any severe side effects should be considered of this therapy